# Flecainide: UK patient leaflet, explained

Source: patient information leaflet for Flecainide Acetate 100mg Tablets (licence PL 16363/0326), approved by the MHRA. Leaflet dated 2026-06-19. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/e6a60375a64776ad51d346d4cdef7ae8e116ad2a

Canonical page: https://pestle.health/uk/flecainide

## What is flecainide for?
Flecainide is an anti-arrhythmic medicine that helps the heart pump normally again. It is used for certain serious heart rhythm problems, often shown by serious palpitations or a fast heartbeat, including when other medicines have not worked well or cannot be tolerated.

## Key facts
- Treatment is normally started under medical supervision, in hospital if necessary, and your doctor will set a personalised dose.
- Your doctor will check the level of flecainide in your blood and take regular ECGs (heart tracings) during treatment.
- Flecainide can itself cause a heart rhythm disorder, either worsening an existing arrhythmia or causing a new one.
- Dizziness and visual disturbances are the most commonly reported side effects, affecting about 15% of patients.
- Never stop taking it without your doctor knowing, because the arrhythmia will no longer be controlled as intended.

## Who should not take flecainide?
- if you are allergic to flecainide or any of the other ingredients
- if you suffer from another heart condition, different from the one for which you are taking this medicine
- if you are also taking certain other antiarrhythmics (sodium channel blockers)
- if you know you have the genetic disease Brugada syndrome, shown by an abnormal ECG

## Check with a doctor or pharmacist first if
- reduced liver function and/or reduced kidney function, as the level of flecainide in the blood may increase
- a permanent pacemaker or temporary pacing electrodes
- cardiac arrhythmias after heart surgery
- you have had a heart attack
- severe bradycardia or pronounced hypotension, which should be corrected before using flecainide
- elderly patients, as flecainide may be removed from the body more slowly and the dose may need adjusting
- certain rapid arrhythmias (AV reciprocation tachycardia), arrhythmias with WPW syndrome and other conduction pathway disorders, or occasional irregular heartbeat (paroxysmal fibrillation) with disabling symptoms: treatment should be under direct hospital or specialist supervision
- low or high potassium in the blood may influence the effect of flecainide and should be corrected before use
- taking activated charcoal (e.g. charcoal tablets) at the same time: only after talking to your doctor, as it affects how well flecainide works

## Side effects that need urgent help
- unexplained jaundice (yellowing of the skin or whites of the eyes) or signs of liver dysfunction: it is advisable to stop flecainide (jaundice is Rare)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- dizziness
- vertigo
- lightheadedness
- visual disturbances
- double vision
- blurred vision
- difficulty focusing

### Common (Up to 1 in 10 people)
- more frequent occurrence of pre-existing arrhythmia (irregular heartbeat)
- shortness of breath
- weakness
- fatigue
- fever
- fluid in the tissues (edema)
- discomfort

### Uncommon (Up to 1 in 100 people)
- decrease in red and white blood cells and platelets
- libido decreased
- depersonalisation/derealisation disorder
- euphoric mood
- increased dream activity
- apathy
- stupor
- erectile dysfunction
- eye irritation
- photophobia
- rapid involuntary movements of the eyes (nystagmus)
- hypertension
- bronchospasm
- irregular heart beat with increased heartbeat
- nausea
- vomiting
- constipation
- abdominal pain
- decreased appetite
- diarrhea
- flatulence
- dry mouth
- taste disturbances
- dermatitis exfoliative
- pain in upper abdomen, fullness (dyspepsia)
- allergic skin reactions such as rashes, hives and baldness
- production of abnormally large volumes of urine (polyuria)
- urinary retention
- swollen lips, tongue and mouth

### Rare (Up to 1 in 1,000 people)
- seeing things that are not there (hallucinations)
- depression
- confusion
- anxiety
- memory loss (amnesia)
- insomnia
- tingling or numbness
- difficulty in controlling movements (ataxia)
- decrease of sensitivity
- increased sweating (hyperhidrosis)
- fainting (syncope)
- tremor
- flushing
- sleepiness
- headache
- nervous disorders e.g. in the arms and legs
- convulsions
- movement disorder (dyskinesia)
- ringing in the ears
- paresis
- speech disorder
- spinning sensation (vertigo)
- lung inflammation (pneumonia)
- elevated liver enzymes reversible on stopping treatment
- yellowing of the skin or whites of the eyes caused by liver or blood problems (jaundice)
- hives (urticaria)

### Very rare (Up to 1 in 10,000 people)
- elevated levels of certain antibodies
- small cloudy spots on the eyeball
- sensitivity to sunlight

### Not known (The leaflet says how often is not known)
- changes in electrocardiogram (ECG)
- increase in pacing threshold in patients with pacemakers or temporary pacing electrodes
- impairment of the conduction between the atria and ventricles of the heart (second or third degree atrioventricular block)
- stopped heart beat
- slower or faster heart beat
- loss of the heart's ability to pump enough blood to the body's tissues
- chest pain
- low blood pressure
- heart attack
- feeling your heart beat
- a pause in the normal cardiac rhythm (sinus arrest)
- appearance of a certain pre-existing heart disease (Brugada syndrome) which was not seen before the treatment with flecainide
- scarring of the lungs or lung disease (interstitial lung disease which causes breathlessness)
- liver disorder
- anorexia
- joint pain
- muscle pain

### Not stated (The leaflet gives no frequency)
- heart rhythm disorder (existing cardiac arrhythmia may worsen or a new cardiac arrhythmia may develop)
- decrease in heart rate (bradycardia)
- increase in heart rate (tachycardia)
- palpitations
- cardiac arrest
- heart failure
- chest pain
- heart attack
- decreased blood pressure (hypotension)

## Other medicines the leaflet mentions
- other sodium channel blockers (class I anti-arrhythmics) such as disopyramide and quinidine
- beta blockers such as propranolol
- amiodarone (for heart conditions)
- calcium channel blockers such as verapamil
- diuretics
- laxatives
- adrenal cortex hormones (corticosteroids)
- astemizole, mizolastine and terfenadine (medicines against allergies)
- ritonavir, lopinavar and indinavir (medicines to treat HIV infections)
- fluoxetine, paroxetine, reboxetine and certain other antidepressants named tricyclic antidepressants
- phenytoin, phenobarbital and carbamazepine (medicines against epilepsy)
- clozapine, haloperidol and risperidol (to treat psychotic disorders)
- quinine, quinidine and halofantrine (medicines against malaria)
- terbinafine (to treat fungal infections)
- cimetidine (an antacid)
- bupropion (anti-smoking medicine)
- digoxin
- activated charcoal (e.g. charcoal tablets)

## Pregnancy and breastfeeding
Flecainide should not be used in pregnancy unless clearly necessary, as it crosses the placenta, and the mother's blood levels should be monitored if it is used; tell your doctor as soon as you suspect you are pregnant or want to have children. Flecainide passes into breast milk, so nursing mothers should not breast-feed while taking it.

## How to take it
- Take exactly as your doctor has told you; your doctor will prescribe a personalised dose and check with them or your pharmacist if unsure.
- Swallow the tablets with enough fluid such as water, on an empty stomach or at least one hour before meals; the daily dose is usually split up over the day.
- The recommended starting dose lies between 50 and 200 mg, and your doctor may increase it to a maximum of 400 mg a day; elderly patients should not exceed 300 mg daily and patients with a permanent pacemaker should not exceed 100 mg twice a day.
- Not for children under 12 years of age.
- If you miss a dose, take it when you remember unless it is almost time for the next one; never take a double dose.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
